PROFEMIGR 150 mg, scored tablet 100 tablets
Active ingredients: KÉTOPROFÈNE
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet100 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROFEMIGR 150 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 100 comprimé(s)
- Marketing authorisation holder
- PHOENIX LABS (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67899241CIP75589807CIP133400955898078Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| KÉTOPROFÈNEcomprimé | 75 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.